24 HR mesalamine 375 MG Extended Release Oral Capsule
1 INDICATIONS AND USAGE Mesalamine extended-release capsules are indicated for the maintenance of remission of ulcerative colitis in adults. Mesalamine extended-release capsules are an aminosalicylate indicated for the maintenance of remission of ulcerative colitis in adults. ( 1 )
Mylan Pharmaceuticals Inc.
CAPSULE GREEN MYLAN MSA 375
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MESALAMINE Extended-Release capsules, USP are available containing 0.375 g of
MESALAMINE, USP. The 0.375 g capsules are hard-shell gelatin capsules with a light green opaque cap and light green opaque body filled with off white to tan colored pellets. The capsules are axially printed with MYLAN over MSA 375 in black ink on cap and body. They are available as follows: NDC 0378-1375-78 bottles of 120 capsules Storage: Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.
More pills like CAPSULE MYLAN MSA 375